Literature DB >> 15878317

Anabolic actions of PTH (1-34): use of a novel tissue engineering model to investigate temporal effects on bone.

Glenda J Pettway1, Abraham Schneider, Amy J Koh, Effendi Widjaja, Michael D Morris, Jeffrey A Meganck, Steven A Goldstein, Laurie K McCauley.   

Abstract

PTH is in clinical use for the treatment of osteoporosis and is under intensive investigation for its potential in applications of tissue engineering, fracture healing, and implant integration. However, the mechanisms of its action to stimulate bone formation are still unclear. A novel bone tissue engineering model was used to elucidate basic mechanisms of PTH anabolic actions. Ectopic ossicles containing cortical bone, trabecular bone, and a hematopoietic marrow were generated from implanted bone marrow stromal cells (BMSC). One week after implantation, nude mice were administered PTH or vehicle for 1 week (group 1), 3 weeks (group 2), or 7 weeks (group 3). Another group was also treated for 3 weeks, initiated 12 weeks after implantation (group 4). Micro-radiography and histomorphometry revealed increased marrow cellularity in group 1 PTH-treated ossicles, increased bone in group 2 PTH-treated ossicles, and similar amounts of bone in both group 3 and 4 ossicles regardless of treatment. Incidence of phosphate mineral and phosphate mineral to hydroxyproline ratio via Raman spectroscopy were significantly higher after 3 weeks versus 1 week of PTH treatment, but there was no difference between PTH- and vehicle-treated ossicles. Early events of PTH action in group 1 ossicles and the effects of a single injection of PTH on 1- and 2-week-old ossicles were evaluated by Northern blot analysis. Osteocalcin (OC) mRNA was increased after 1 week of intermittent PTH treatment in ossicles and calvaria but an acute injection did not alter OC mRNA. In contrast, a single injection of PTH increased matrix gamma-carboxyglutamic acid protein (MGP) mRNA in 2-week-old ossicles. Differential and temporal-dependent effects of PTH on OC and MGP suggest at the molecular level, that PTH acts to inhibit osteoblast mineralization. However, this does not translate into tissue level alterations. These data indicate that anabolic actions of PTH in ectopic ossicles are temporally dependent on the BMSC implanted and suggest that cell implantation strategies are particularly responsive to PTH.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15878317     DOI: 10.1016/j.bone.2005.02.015

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  41 in total

Review 1.  T cells: critical bone regulators in health and disease.

Authors:  Roberto Pacifici
Journal:  Bone       Date:  2010-05-07       Impact factor: 4.398

Review 2.  Catabolic and anabolic actions of parathyroid hormone on the skeleton.

Authors:  B C Silva; A G Costa; N E Cusano; S Kousteni; J P Bilezikian
Journal:  J Endocrinol Invest       Date:  2011-09-23       Impact factor: 4.256

3.  An in vivo model to study and manipulate the hematopoietic stem cell niche.

Authors:  Junhui Song; Mark J Kiel; Zhou Wang; Jingcheng Wang; Russell S Taichman; Sean J Morrison; Paul H Krebsbach
Journal:  Blood       Date:  2010-01-28       Impact factor: 22.113

Review 4.  Raman assessment of bone quality.

Authors:  Michael D Morris; Gurjit S Mandair
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

5.  Delayed short-course treatment with teriparatide (PTH(1-34)) improves femoral allograft healing by enhancing intramembranous bone formation at the graft-host junction.

Authors:  Masahiko Takahata; Edward M Schwarz; Tony Chen; Regis J O'Keefe; Hani A Awad
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

6.  Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo.

Authors:  Didier Merciris; Caroline Marty; Corinne Collet; Marie-Christine de Vernejoul; Valerie Geoffroy
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

7.  Confocal laser Raman microspectroscopy of biomineralization foci in UMR 106 osteoblastic cultures reveals temporally synchronized protein changes preceding and accompanying mineral crystal deposition.

Authors:  Chuanyi Wang; Yong Wang; Nichole T Huffman; Chaoying Cui; Xiaomei Yao; Sharon Midura; Ronald J Midura; Jeff P Gorski
Journal:  J Biol Chem       Date:  2008-12-30       Impact factor: 5.157

8.  The skeletal impact of the chemotherapeutic agent etoposide.

Authors:  A J Koh; B P Sinder; P Entezami; L Nilsson; L K McCauley
Journal:  Osteoporos Int       Date:  2017-04-20       Impact factor: 4.507

9.  Pulsatile release of parathyroid hormone from an implantable delivery system.

Authors:  Xiaohua Liu; Glenda J Pettway; Laurie K McCauley; Peter X Ma
Journal:  Biomaterials       Date:  2007-06-18       Impact factor: 12.479

10.  Calcium Sensing Receptor Function Supports Osteoblast Survival and Acts as a Co-Factor in PTH Anabolic Actions in Bone.

Authors:  Saja A Al-Dujaili; Amy J Koh; Ming Dang; Xue Mi; Wenhan Chang; Peter X Ma; Laurie K McCauley
Journal:  J Cell Biochem       Date:  2016-02-19       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.